Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy

Endocrine therapy is the mainstay of treatment of estrogen-receptor-positive (ER+) breast cancer with an overall survival benefit. However, some adaptive mechanisms in the tumor emerge leading to the development of a resistance to this therapy. A better characterization of this process is needed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Augereau, Paule, Patsouris, Anne, Bourbouloux, Emmanuelle, Gourmelon, Carole, Abadie Lacourtoisie, Sophie, Berton Rigaud, Dominique, Soulié, Patrick, Frenel, Jean Sebastien, Campone, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424863/
https://www.ncbi.nlm.nih.gov/pubmed/28529550
http://dx.doi.org/10.1177/1758834017693195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424863/
https://www.ncbi.nlm.nih.gov/pubmed/28529550
http://dx.doi.org/10.1177/1758834017693195

Ejemplares similares